Editorial - (2020) Volume 12, Issue 2
Received: 02-Apr-2020 Published: 24-May-2020, DOI: 10.35248/0975-0851.20.12.394
I am pleased to introduce Journal of Bioequivalence & Bioavailability (JBB) is an academic journal that encompasses a wide range of current research on FDA Bioequivalence, Bioequivalence antipsychotics, Bioequivalence anticancers, Bioequivalence antidiuretics, Bioequivalence antipsychotics, BA/BE Studies, Biosimilars, Advances in Bioavailability and offers a promising platform for the authors to make their valuable contributions towards the journal. I am pleased to announce that, all issues of volume 11 were published online well within the time and the print issues were also brought out and dispatched within 30 days of publishing the issue online during the year of 2019.
The journal aims to publish the most complete and reliable source of information on the advanced and very latest research topics related to the recent advancements in Bioequivalence, Bioequivalence antipsychotics, Bioequivalence anticancers, Bioequivalence antidiuretics, Bioequivalence antipsychotics, BA/ BE Studies, Biosimilars, Advances in Bioavailability.
All published articles of this journal are included in the indexing and abstracting coverage of CAS Source Index (CASSI), Index Copernicus, Google Scholar, Sherpa Romeo, Academic Journals Database, Open J Gate, Genamics Journal Seek, Academic Keys, Journal TOCs, China National Knowledge Infrastructure (CNKI), Cite Factor, Scimago, Ulrich's Periodicals Directory, Electronic Journals Library, Ref Seek, Hamdard University, EBSCO A-Z, OCLC- WorldCat, SWB online catalog, Virtual Library of Biology (vifabio), Publons, MIAR, University Grants Commission and Geneva Foundation for Medical Education and Research.
During the calendar year of 2019, JBB received a total of 9 manuscript, out of which 3 articles (30%) were rejected in the preliminary screening due to plagiarism or being out of the format and peer review process. During 2019 around 6 articles were subjected for publication after they are accepted in the peer review process. In the 2 issues of Volume 11 published during the year 2019, a total of 6 articles were published (at an average of 1 articles per issue) of which, articles were published from authors all around the world. Globally articles have been accessed by the research scientists and also cited.
During the calendar year 2019, a total of three Editors, ten reviewers joined the board of JBB and contributed their valuable services towards contribution as well as publication of articles, and their valuable reviewer comments will beneficial to publish quality of article in the journal.
I take this opportunity to acknowledge the contribution of (Dr. Michael Retsky) during the final editing of articles published and the support rendered by the editorial assistant, in bringing out issues of JBB in time. I would also like to express my gratitude to all the authors, reviewers, the publisher, the advisory and the editorial board of JBB, the office bearers for their support in bringing out yet another volume of JBB and look forward to their unrelenting support to bring out the Volume 12 of JBB in scheduled time.
Citation: Sahoo H (2020) Editorial Highlights for Journal of Bioequivalence & Bioavailability. J Bioequiv Availab 12:394. doi: 10.35248/0975-0851.20.12.394
Copyright: © 2020 Sahoo H. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.